Respiratory infections on the rise in Victoria

August 26, 2026

In Victoria, cases of influenza (flu) and COVID-19 are increasing, while respiratory syncytial virus (RSV) cases remain high after peaking in July. Health service visits for respiratory illnesses have also been increasing.

Flu, COVID-19 and RSV are among the respiratory infections that typically peak during winter and early spring. This year, increases in these infections are occurring later than usual.

Respiratory infections can affect people of all age groups. Young children, pregnant women, older adults and people with underlying medical conditions or a weakened immune system are most at risk of severe illness and hospital admission from respiratory infections.

Recommendations for healthcare professionals:

  • Ensure those most at risk of severe illness are up to date with vaccinations for respiratory infections such as flu, COVID-19 and RSV: 
  • Offer annual influenza vaccination to everyone aged 6 months and older.
  • Offer Abrysvo® RSV vaccine to eligible pregnant women (from 28 weeks), nirsevimab (Beyfortus™) RSV monoclonal antibody to eligible infants and Arexvy® RSV vaccine in eligible older adults.
  • Offer COVID-19 vaccination and boosters for recommended people based on age, risk factors and immune status.
  • Encourage catch up vaccination for patients who are not up to date with routine immunisations.
  • Discuss testing and the early use of anti-viral treatment for flu and COVID-19 for high-risk individuals.
  • Stay up to date on trends of acute respiratory infections in Victoria through the Victorian Department of Health's Victorian respiratory surveillance report
Respiratory surveillance report

Latest news

September 13, 2026
South Eastern Melbourne PHN has launched the Clinical and Referral Guidance Hub (the Hub), a new platform providing primary care professionals in south east Melbourne with centralised access to local referral information and clinical guidance.
September 10, 2026
Sublocade® (long acting injectable buprenorphine) will be discontinued in Australia after 31 December 2026. The decision is not related to safety, quality or efficacy concerns and people currently receiving Sublocade® should continue their treatment as prescribed.
September 2, 2026
Thursday 10 September is World Suicide Prevention Day, a global day to raise awareness of suicide prevention and encourage open, compassionate conversations about suicide.